Circadian rhythms are stable biological systems that change incredibly slowly. Evening types who try to force themselves to wake up early typically fail to fall asleep earlier, resulting in chronic sleep deprivation and its associated negative health and performance consequences.

Insomnia is often maintained by 'conditioned arousal,' where your brain learns to associate your bed with being awake (from working, watching TV, or worrying in it). To break this, if you're awake for 20 minutes, get out of bed until you're sleepy again to re-teach your brain that bed is only for sleep.

The physical decline, decreased mobility, and frailty common in the elderly, even without a specific diagnosed disease, can be directly attributed to the accumulation of senescent cells. This links a macro-level health observation to a specific cellular process, identifying a tangible target for therapeutic intervention against age-related weakness.

It's biologically normal for every human to wake between 1-3 AM. This is when your core body temperature hits its lowest point, and the brief arousal is a survival mechanism to prevent hypothermia. The issue isn't waking up, but rather failing to immediately fall back asleep.

After age 40, NAD deficiency impacts three critical cellular functions: it starves mitochondria of energy, impairs sirtuins that regulate homeostasis, and hinders PARPs responsible for DNA repair, increasing cancer risk.

Research shows restricting sleep to five hours a night for one week can decrease a man's testosterone by 15%. This significant drop is metabolically equivalent to aging by a decade, highlighting the critical and immediate impact of sleep on hormonal health.

The scientific consensus is shifting: aging is not random decay but a predictable process of epigenetic errors. Over time, the molecular "switches" that turn genes on and off get scrambled. Technologies like Yamanaka factors can reset these switches, effectively reverting cells to a youthful state and reversing age-related diseases.

Current wearables passively track sleep. The next generation of technology will actively induce and manage sleep by 'writing' to our biology—for example, using devices that directly cool the body's core through the palms or eye masks that guide eye movements to accelerate sleep onset.

Unlike sedatives like Ambien, a new class of medication (DORAs) works by dialing down the brain's wakefulness chemical (orexin). This allows for naturalistic sleep that is functionally beneficial, proven to increase the brain's cleansing of beta amyloid and tau protein, which are linked to Alzheimer's disease.